Skip to main content

Breast Cancer

Breast Cancer

Real-World Tumor Response of Palbociclib plus Letrozole versus Letrozole for Metastatic Breast Cancer in US Clinical Practice

Breast Cancer

Olaparib Monotherapy in Germline BRCA Mutation–Positive, HER2-Negative Metastatic Breast Cancer in the Real-World Setting

Breast Cancer

CDK4/6 Inhibitor Treatment Patterns and Outcomes in Metastatic Breast Cancer by Germline BRCA Mutation Status: A Real-World Evidence Study

Breast Cancer

A Summary of PARP Inhibitors for the Treatment of Breast Cancer

Breast Cancer

Overall Survival in Patients with HR-Positive, HER2-Negative, Advanced or Metastatic Breast Cancer Treated with a CDK4/6 Inhibitor plus Fulvestrant: An FDA Pooled Analysis

Breast Cancer

Real-World Patient-Reported Outcomes, Clinical Profile, and Treatment Patterns in a Subset of Patients with HR-Positive, HER2-Negative, Advanced Breast Cancer with Poor Prognostic Factors

Breast Cancer

A Web-Based Survey on Suggested Modifications in the Management of Patients with Breast Cancer During the COVID-19 Pandemic

Breast Cancer

Polyunsaturated Fatty Acids, Exercise, and Fatigue in Breast Cancer

Breast Cancer

Highlights in Breast Cancer from ASCO 2021: An Interview with Virginia Kaklamani, MD

Case Reports, Breast Cancer, Adverse Events

Hypersensitivity Reactions to Taxanes and Subsequent Treatment with Nab-Paclitaxel: Case Reports of 2 Women with Early-Stage Breast Cancer

Kevin Straughn, PharmD, Robin Hardie-Hood, MD, Jordan Carrera, PharmD, BCPS, BCOP

Kevin Straughn, PharmD; Robin Hardie-Hood, MD; Jordan Carrera, PharmD, BCPS, BCOP

1
2
3
4
5
6
7

Page 4 of 11
Results 31 - 40 of 101